Skip to main content
Erschienen in: Urolithiasis 4/2011

01.08.2011 | Original Paper

Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis

verfasst von: Ahmet Yaser Muslumanoglu, Murat Binbay, Emrah Yuruk, Tolga Akman, Abdulkadir Tepeler, Tarik Esen, Ahmet Hamdi Tefekli

Erschienen in: Urolithiasis | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The worldwide prevalence and epidemiologic characteristics of urolithiasis appear to have changed in the last decade. This study aims to update the current understanding of the disease in Turkey. A representative sample, totalling 2,468 participants between 18 and 70 years of age from 33 Turkish provinces, was enrolled in this cross-sectional study conducted with a professional market investigation company. Participants were evaluated with face-to-face interviews by medical students using a standard questionnaire. Of the 2,468 participants, 274 (11.1%) reported a history of urinary stone disease diagnosed by a physician and an additional 52 (2.1%) had at least one lifetime episode of colic pain. The annual incidence of urolithiasis in 2008 was 1.7%. The male:female ratio was 1:1 in participants with urolithiasis. A family history of urolithiasis was found in 28.5% of the first-degree relatives of the stone formers, compared to 4.4% of the first-degree relatives of the stone-free participants (p = 0.01). Compared to other ethnic groups, the population of Turkish origin had a statistically significant decreased risk of urolithiasis (p = 0.006). Though not statistically significant (p > 0.05), urolithiasis showed a trend toward a geographical distribution within the country, in which southeastern Anatolia and the Aegean regions had higher frequencies compared to the Black Sea, and central Anatolian and eastern Anatolian regions. Urinary stone disease is a severe problem in Turkey, with high prevalence and incidence rates, which differ significantly between ethnic groups. Moreover, current findings demonstrate a demographic shift, with an increased prevalence of stone disease in female subjects.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Smith LH (1989) The medical aspects of urolithiasis: an overview. J Urol 141:707PubMed Smith LH (1989) The medical aspects of urolithiasis: an overview. J Urol 141:707PubMed
2.
Zurück zum Zitat Trinchieri A (1996) Epidemiology of urolithiasis. Arch It Urol Androl 68:203–249 Trinchieri A (1996) Epidemiology of urolithiasis. Arch It Urol Androl 68:203–249
3.
Zurück zum Zitat Curhan GC (2007) Epidemiology of stone disease. Urol Clin N Am 34:287–293CrossRef Curhan GC (2007) Epidemiology of stone disease. Urol Clin N Am 34:287–293CrossRef
4.
Zurück zum Zitat Akinci M, Esen T, Tellaloglu S (1991) Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol 20:200–203PubMed Akinci M, Esen T, Tellaloglu S (1991) Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol 20:200–203PubMed
5.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef
6.
Zurück zum Zitat Hesse A, Brandle E, Wilbert D et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 versus 2000. Eur Urol 44(6):709–713PubMedCrossRef Hesse A, Brandle E, Wilbert D et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 versus 2000. Eur Urol 44(6):709–713PubMedCrossRef
7.
Zurück zum Zitat Mahon FB Jr, Waters RF (1973) A critical review of stone manipulation: a 5 year study. J Urol 110:387–388PubMed Mahon FB Jr, Waters RF (1973) A critical review of stone manipulation: a 5 year study. J Urol 110:387–388PubMed
8.
Zurück zum Zitat Finlayson B (1974) Symposium on renal lithiasis. Renal lithiasis in review. Urol Clin North Am 1:181–212PubMed Finlayson B (1974) Symposium on renal lithiasis. Renal lithiasis in review. Urol Clin North Am 1:181–212PubMed
9.
Zurück zum Zitat Kim HH, Jo MK, Kwak C et al (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517–521PubMedCrossRef Kim HH, Jo MK, Kwak C et al (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517–521PubMedCrossRef
10.
Zurück zum Zitat Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence and associated risk factors. Urol Res 35:73–82PubMedCrossRef Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence and associated risk factors. Urol Res 35:73–82PubMedCrossRef
11.
Zurück zum Zitat Yoshida O, Okada Y (1990) Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int 45:104–111PubMedCrossRef Yoshida O, Okada Y (1990) Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int 45:104–111PubMedCrossRef
12.
Zurück zum Zitat Scales CD, Curtis LH, Norris RD et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982PubMedCrossRef Scales CD, Curtis LH, Norris RD et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982PubMedCrossRef
13.
Zurück zum Zitat Trinchieri A, Coppi F, Montarani E et al (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last 10 years. Eur Urol 37:23–25PubMedCrossRef Trinchieri A, Coppi F, Montarani E et al (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last 10 years. Eur Urol 37:23–25PubMedCrossRef
14.
Zurück zum Zitat Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ et al (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172:159PubMedCrossRef Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ et al (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172:159PubMedCrossRef
15.
Zurück zum Zitat Hedley AA, Ogden CL, Johnson JL, Carroll MD, Curtin LR, Flegal KM (2004) Prevalance of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA 291:2847PubMedCrossRef Hedley AA, Ogden CL, Johnson JL, Carroll MD, Curtin LR, Flegal KM (2004) Prevalance of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA 291:2847PubMedCrossRef
16.
Zurück zum Zitat Curhan G, Willett W, Rimm E et al (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8:1568–1573PubMed Curhan G, Willett W, Rimm E et al (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8:1568–1573PubMed
17.
Zurück zum Zitat Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B (1985) Family history of renal stones in recurrent stone patients. Br J Urol 57:370–374PubMedCrossRef Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B (1985) Family history of renal stones in recurrent stone patients. Br J Urol 57:370–374PubMedCrossRef
18.
Zurück zum Zitat Parivar F, Low RK, Stoller ML (1996) The influence of diet on urinary stone disease. J Urol 155:432–440PubMedCrossRef Parivar F, Low RK, Stoller ML (1996) The influence of diet on urinary stone disease. J Urol 155:432–440PubMedCrossRef
19.
Zurück zum Zitat Johnson CM, Wilson DM, O’Fallon WM et al (1979) Renal stone epidemiology: a 25 year study in Rochester, Minnesota. Kidney Int 16:624–631PubMedCrossRef Johnson CM, Wilson DM, O’Fallon WM et al (1979) Renal stone epidemiology: a 25 year study in Rochester, Minnesota. Kidney Int 16:624–631PubMedCrossRef
20.
Zurück zum Zitat Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Eng J Med 346:2069–2073CrossRef Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Eng J Med 346:2069–2073CrossRef
21.
Zurück zum Zitat Ettinger B, Pak CY, Citron JT et al (1997) Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073PubMedCrossRef Ettinger B, Pak CY, Citron JT et al (1997) Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073PubMedCrossRef
22.
Zurück zum Zitat Ljunghall S, Hedstrand H (1975) Epidemiology of renal stones in a middle-aged male population. Acta Med Scand 197:439–445PubMedCrossRef Ljunghall S, Hedstrand H (1975) Epidemiology of renal stones in a middle-aged male population. Acta Med Scand 197:439–445PubMedCrossRef
23.
Zurück zum Zitat Ettinger B, Citron JT, Livermore B et al (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679–684PubMed Ettinger B, Citron JT, Livermore B et al (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679–684PubMed
24.
Zurück zum Zitat Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H (1994) Demographic and geographic variability of kidney stones in the United States. Kid Int 46:893–899CrossRef Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H (1994) Demographic and geographic variability of kidney stones in the United States. Kid Int 46:893–899CrossRef
25.
Zurück zum Zitat Soucie JM, Coates RJ, McClellan W, Austin H, Thun M (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143(5):487–495PubMed Soucie JM, Coates RJ, McClellan W, Austin H, Thun M (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143(5):487–495PubMed
Metadaten
Titel
Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis
verfasst von
Ahmet Yaser Muslumanoglu
Murat Binbay
Emrah Yuruk
Tolga Akman
Abdulkadir Tepeler
Tarik Esen
Ahmet Hamdi Tefekli
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 4/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0346-6

Weitere Artikel der Ausgabe 4/2011

Urolithiasis 4/2011 Zur Ausgabe

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.